Latest news
Hemogenyx Pharmaceuticals Signs Letter Of Intent With Vilnius University Hospital Santaros Klinikos For FLT3-Directed CAR-T Cell Therapy Clinical Application And Research - marketscreener.commarketscreener.com · Wed, 29 Jul 2026 07:00:00 GMTHemogenyx Pharmaceuticals Enters Letter of Intent with Vilnius University Hospital to Advance HG-CT-1 CAR-T Therapy for FLT3-Positive Leukemia - Kalkine MediaKalkine Media · Wed, 29 Jul 2026 07:00:00 GMTHemogenyx Pharmaceuticals PLC Announces Collaboration and Company Update - Caledonian RecordCaledonian Record · Wed, 29 Jul 2026 06:01:18 GMT